• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药品选择:法律问题。

Drug product selection: legal issues.

作者信息

Christensen T P, Kirking D M, Ascione F J, Welage L S, Gaither C A

机构信息

College of Pharmacy, North Dakota State University, Fargo 58105, USA.

出版信息

J Am Pharm Assoc (Wash). 2001 Nov-Dec;41(6):868-74. doi: 10.1016/s1086-5802(16)31328-6.

DOI:10.1016/s1086-5802(16)31328-6
PMID:11765112
Abstract

OBJECTIVE

To review the potential legal liability of the pharmacist in the drug product selection process.

DATA SOURCES

Published articles identified through MEDLINE, published law reviews identified through InfoTrac, and appellate court decisions. Search terms used included pharmacist liability, drug product selection, and generic substitution. Additional articles, books, and appellate court decisions were identified from the bibliographies of retrieved articles and citations in appellate court decisions.

DATA SYNTHESIS

Pharmacists engaging in drug product selection are civilly liable under three legal theories: negligence, express or implied warranties, and strict product liability. Potential criminal liability includes prosecution for insurance fraud, deceptive business practices, and violation of state drug product selection laws and regulation.

CONCLUSION

Pharmacists increase their liability when engaging in drug product selection, but the increase is small. Still, the law continues to evolve as pharmacists seek expanded roles and responsibilities. When courts give closer examination to pharmacists' expanded role, it is likely that pharmacists' liability will increase.

摘要

目的

回顾药剂师在药品选择过程中可能承担的法律责任。

数据来源

通过医学在线数据库(MEDLINE)检索到的已发表文章、通过信息检索系统(InfoTrac)检索到的已发表法律评论以及上诉法院判决。使用的检索词包括药剂师责任、药品选择和通用名替换。从检索到的文章参考文献和上诉法院判决中的引用中识别出其他文章、书籍和上诉法院判决。

数据综合

从事药品选择的药剂师在三种法律理论下承担民事责任:过失、明示或默示保证以及严格产品责任。潜在的刑事责任包括因保险欺诈、欺骗性商业行为以及违反州药品选择法律法规而被起诉。

结论

药剂师在从事药品选择时责任有所增加,但增幅较小。然而,随着药剂师寻求扩大角色和职责,法律仍在不断演变。当法院更仔细地审查药剂师扩大的角色时,药剂师的责任可能会增加。

相似文献

1
Drug product selection: legal issues.药品选择:法律问题。
J Am Pharm Assoc (Wash). 2001 Nov-Dec;41(6):868-74. doi: 10.1016/s1086-5802(16)31328-6.
2
Pharmacist liability.药剂师责任
Am J Hosp Pharm. 1993 Jul;50(7):1429-36.
3
Medicinal products liability of the pharmacists: an overview of some emerging legal issues in Nigeria.药剂师的药品责任:尼日利亚一些新出现的法律问题概述。
World Health Popul. 2008 Mar;10(1):5-17. doi: 10.12927/whp.2008.19597.
4
Prosecution of harmful errors decided by outside forces.对由外部力量决定的有害错误的追究。
Am J Health Syst Pharm. 2009 Jul 1;66(13):1158-9. doi: 10.2146/news090056.
5
Pharmacists' liability: what my pharmacy law professor did not cover.
Int J Pharm Compd. 2013 Jul-Aug;17(4):290-3.
6
Pharmacists' responsibility and potential liability regarding generic substitition.
Med Law. 2009 Dec;28(4):697-704.
7
Pharmacists' liability into the year 2000.到2000年药剂师的责任。
J Am Pharm Assoc (Wash). 1998 Nov-Dec;38(6):747-52; quiz 753-4. doi: 10.1016/s1086-5802(16)30396-5.
8
Legal implications of diagnosis-related groups.诊断相关分组的法律影响。
Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):597-9. doi: 10.1177/106002808602000721.
9
Whose liability is it? The pharmacist on trial.
Am Pharm. 1994;NS34 Suppl 1:1-16; quiz 17-9.
10
Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.公平处方:一种新方法解决名牌和仿制药制造商的侵权责任。
Duke Law J. 2011 Feb;60(5):1123-91.

引用本文的文献

1
Regulatory issues related to the use of sodium hypochlorite solutions in endodontics.与次氯酸钠溶液在牙髓病学中的使用相关的监管问题。
Int Endod J. 2025 Mar;58(3):368-378. doi: 10.1111/iej.14174. Epub 2024 Nov 27.
2
Considerations for the US health-system pharmacist in a world of biosimilars.生物类似药时代美国医疗系统药剂师需考虑的因素
Drugs Context. 2020 Feb 25;9. doi: 10.7573/dic.2019-12-1. eCollection 2020.
3
Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.
管理式医疗受益人群中从品牌药转换为仿制药后他汀类药物依从性的预测因素。
J Gen Intern Med. 2014 Oct;29(10):1372-8. doi: 10.1007/s11606-014-2933-7. Epub 2014 Jun 24.
4
Understanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication.了解患者使用通用抗癫痫药物的观点:给医生改善医患沟通的深刻启示。
BMC Neurol. 2009 Mar 17;9:11. doi: 10.1186/1471-2377-9-11.